Clinical trial
Study of the Benefit / Risk Ratio of Oral Anticoagulation in Hemodialysis Patients With Atrial Fibrillation
NCT02886962 is registered in ClinicalTrials.gov with University Hospital, Strasbourg, France as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study of the Benefit / Risk Ratio of Oral Anticoagulation in Hemodialysis Patients With Atrial Fibrillation
- Lead sponsor
- University Hospital, Strasbourg, France
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- July 12, 2017
- Completion date
- December 1, 2023
- Enrollment
- 50 (actual)
- Sites
- 25
Conditions
As the registry lists them; a condition with its own page is linked.